Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors
- 1 December 2001
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 20 (12) , 1274-1281
- https://doi.org/10.1016/s1053-2498(01)00364-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Invasive AspergillosisClinical Infectious Diseases, 1998
- Aspergillus Airway Colonization and Invasive Disease After Lung TransplantationChest, 1997
- Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxisTransplantation Proceedings, 1997
- Aspergillus INFECTION IN SINGLE AND DOUBLE LUNG TRANSPLANT RECIPIENTSTransplantation, 1996
- Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsAnnals of Hematology, 1995
- Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsAntimicrobial Agents and Chemotherapy, 1994
- A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged NeutropeniaLeukemia & Lymphoma, 1992
- Ulcerative Tracheobronchitis after Lung Transplantation: A New Form of Invasive AspergillosisAmerican Review of Respiratory Disease, 1991
- Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1988